Company / PP&E per Share
Vistagen Therapeutics, Inc. PP&E per Share History
FY2011-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E per Share
$0.01
FY2021
5-year range
$0.01 / $0.18
FY2017-FY2021
Trend
-78.8%
vs FY2020
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $0.18 to $0.01 over the past 4 years.
Based on SEC 10-K filings.
0.01 in FY2021 with a 10-year CAGR of -4.9%.
Declined from $0.18 to $0.01 over the past 4 years.
PP&E per Share over time
Growth rates
- 3-Year CAGR
- -40.4%
- 5-Year CAGR
- -
- 10-Year CAGR
- -4.9%
Key checks
Key Insights
- In FY2021, pp&e per share decreased 78.8% year-over-year.
- Peak pp&e per share was recorded in FY2017.
- Lowest pp&e per share in the period was in FY2012.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -7.17 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | $0.01 | -78.8% |
| FY2018 | $0.04 | -77.9% |
| FY2017 | $0.18 | +1741.1% |
| FY2014 | $0.01 | +48.8% |
| FY2012 | $0.01 | -52.8% |
| FY2011 | $0.01 | - |
As of FY2021 · SEC 10-K · Updated Jun 28, 2026